BACKGROUND: Matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) is an emerging technology newly applied to identifying bacterial and yeast strains. The aim of this study was to evaluate the clinical performance of the VITEK(®) MS system in the identification of bacteria and yeast strains routinely isolated from clinical samples. METHODS: We prospectively analyzed routine MALDI-TOF mass spectrometry identification in parallel with conventional phenotypic identification of bacteria and yeasts regardless of phylum or source of isolation. Discordant results were resolved with 16S rDNA or internal transcribed spacer (ITS) gene sequencing. Colonies (a single deposit on a MALDI disposable target without any prior extraction step) were analyzed using the VITEK(®) MS system. Peptide spectra acquired by the system were compared with the VITEK(®) MS IVD database Version 2.0, and the identification scores were recorded. RESULTS: Of the 1,181 isolates (1,061 bacterial isolates and 120 yeast isolates) analyzed, 99.5% were correctly identified by MALDI-TOF mass spectrometry; 95.7% identified to the species level, 3.6% identified to the genus level, and 0.3% identified within a range of species belonging to different genera. Conversely, 0.1% of isolates were misidentified and 0.4% were unidentified, partly because the species were not included in the database. Re-testing using a second deposit provided a successful identification for 0.5% of isolates unidentified with the first deposit. Our results show that the VITEK(®) MS system has exceptional performance in identifying bacteria and yeast by comparing acquired peptide spectra to those contained in its database. CONCLUSIONS: MALDI-TOF mass spectrometry is a rapid, accurate, and relatively inexpensive method for bacterial and yeast identification. Our results demonstrate that the VITEK(®) MS system is a fast and reliable technique, and has the potential to replace conventional phenotypic identification for most bacterial and yeast strains routinely isolated in clinical microbiology laboratories.
BACKGROUND: Matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) is an emerging technology newly applied to identifying bacterial and yeast strains. The aim of this study was to evaluate the clinical performance of the VITEK(®) MS system in the identification of bacteria and yeast strains routinely isolated from clinical samples. METHODS: We prospectively analyzed routine MALDI-TOF mass spectrometry identification in parallel with conventional phenotypic identification of bacteria and yeasts regardless of phylum or source of isolation. Discordant results were resolved with 16S rDNA or internal transcribed spacer (ITS) gene sequencing. Colonies (a single deposit on a MALDI disposable target without any prior extraction step) were analyzed using the VITEK(®) MS system. Peptide spectra acquired by the system were compared with the VITEK(®) MS IVD database Version 2.0, and the identification scores were recorded. RESULTS: Of the 1,181 isolates (1,061 bacterial isolates and 120 yeast isolates) analyzed, 99.5% were correctly identified by MALDI-TOF mass spectrometry; 95.7% identified to the species level, 3.6% identified to the genus level, and 0.3% identified within a range of species belonging to different genera. Conversely, 0.1% of isolates were misidentified and 0.4% were unidentified, partly because the species were not included in the database. Re-testing using a second deposit provided a successful identification for 0.5% of isolates unidentified with the first deposit. Our results show that the VITEK(®) MS system has exceptional performance in identifying bacteria and yeast by comparing acquired peptide spectra to those contained in its database. CONCLUSIONS: MALDI-TOF mass spectrometry is a rapid, accurate, and relatively inexpensive method for bacterial and yeast identification. Our results demonstrate that the VITEK(®) MS system is a fast and reliable technique, and has the potential to replace conventional phenotypic identification for most bacterial and yeast strains routinely isolated in clinical microbiology laboratories.
Entities:
Keywords:
Matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS); VITEK-MS; bacteria; identification; yeasts
Authors: Amy Fothergill; Vyjayanti Kasinathan; Jay Hyman; John Walsh; Tim Drake; Yun F Wayne Wang Journal: J Clin Microbiol Date: 2012-12-19 Impact factor: 5.948
Authors: O Garner; A Mochon; J Branda; C-A Burnham; M Bythrow; M Ferraro; C Ginocchio; R Jennemann; R Manji; G W Procop; S Richter; J Rychert; L Sercia; L Westblade; M Lewinski Journal: Clin Microbiol Infect Date: 2013-08-09 Impact factor: 8.067
Authors: Hercules Moura; Adrian R Woolfitt; Maria G Carvalho; Antonis Pavlopoulos; Lucia M Teixeira; Glen A Satten; John R Barr Journal: FEMS Immunol Med Microbiol Date: 2008-06-05
Authors: Reiner Schaumann; Nicolas Knoop; Gelimer H Genzel; Kevin Losensky; Christiane Rosenkranz; Catalina S Stîngu; Wolfgang Schellenberger; Arne C Rodloff; Klaus Eschrich Journal: Open Microbiol J Date: 2013-06-28
Authors: Fredrik Boulund; Roger Karlsson; Lucia Gonzales-Siles; Anna Johnning; Nahid Karami; Omar Al-Bayati; Christina Åhrén; Edward R B Moore; Erik Kristiansson Journal: Mol Cell Proteomics Date: 2017-04-18 Impact factor: 5.911
Authors: Elenice R A Rodrigues; Alex G Ferreira; Robson S Leão; Cassiana C F Leite; Ana Paula Carvalho-Assef; Rodolpho M Albano; Elizabeth A Marques Journal: J Clin Microbiol Date: 2015-12 Impact factor: 5.948
Authors: Hyun Seung Lee; Jong Hee Shin; Min Ji Choi; Eun Jeong Won; Seung Jung Kee; Soo Hyun Kim; Myung Geun Shin; Soon Pal Suh Journal: Ann Lab Med Date: 2017-05 Impact factor: 3.464
Authors: Simone Konnerth; Gisela Rademacher; Sebastian Suerbaum; Stefan Ziesing; Ludwig Sedlacek; Ralf-Peter Vonberg Journal: BMC Res Notes Date: 2014-06-27